Skip to main content
. 2018 Jul 11;362:k2644. doi: 10.1136/bmj.k2644

Table 2.

Relative and absolute excess risks of cancers of breast, ovary, and corpus uteri among 225 786 women who underwent assisted reproduction in Great Britain, 1991-2010, including and excluding the first year after the start of treatment

Type of cancer Follow-up (No of person years) No of observed cancers No of expected cancers Standardised incidence ratio (95% CI) Absolute excess risk (95% CI) per 100 000 person years at risk
Including first year of follow-up
Breast* 2 257 789 2578 2641.2 0.98 (0.94 to 1.01) −2.8 (−7.1 to 1.8)
Corpus uteri† 2 257 789 164 146.9 1.12 (0.95 to 1.30) 0.8 (−0.3 to 2.0)
Ovary‡ 2 257 789 405 291.82 1.39 (1.26 to 1.53) 5.0 (3.3 to 6.9)
Excluding first year of follow-up
Breast* 2 004 121 2384 2501.6 0.95 (0.92 to 0.99) −5.9 (−10.6 to −1.0)
Corpus uteri† 2 004 121 157 141.79 1.11 (0.94 to 1.30) 0.8 (−0.4 to 2.1)
Ovary‡ 2 004 121 356 271.9 1.31 (1.18 to 1.45) 4.2 (2.44 to 6.10)
*

Breast cancer=ICD-9 codes 1740-1749, 2330, and 2383; ICD-10 codes C500-C509, D050-D059, and D486.

Corpus uteri cancer=ICD-9 codes 1820-1828 and ICD-10 code C54.

Ovarian cancer=ICD-9 codes 1830-1839 and 2362; ICD-10 codes C56, C570-C574, C481, C482, and D391.